MetLife director granted 273 deferred shares

MetLife Inc. director Daniel S. Glaser reported an acquisition of 273 shares of common stock as a grant under non-management director compensation arrangements.

Rhea-AI Filing Summary

MetLife Inc. director Daniel S. Glaser reported an acquisition of 273 shares of common stock as a grant under non-management director compensation arrangements. The grant was valued at $75.34 per share, and he elected to defer receipt of these shares into the MetLife Deferred Compensation Plan for Non-Management Directors.

Following this award, Glaser directly holds 1,380 common shares. The filing also notes 198 common shares held indirectly in a Grantor Retained Annuity Trust, which were previously reported as directly owned due to an administrative error and are now correctly classified as indirectly held.

Insider Trade Summary

Grant/Award: 273 shares

Grant/Award 2 txns

Insider Glaser Daniel S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	273	$75.34	$21K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,380 shares (Direct); Common Stock — 198 shares (Indirect, By GRAT)

Footnotes (2)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
2. F2. These shares are held in a Grantor Retained Annuity Trust (GRAT) and were previously reported as directly owned due to administrative error.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MetLife (MET) director Daniel Glaser report?

Daniel S. Glaser reported receiving 273 MetLife common shares as a grant. The award is part of non-management director compensation and was valued at $75.34 per share, with the shares deferred into a company deferred compensation plan.

How many MetLife (MET) shares does Daniel Glaser hold after this Form 4/A?

After the reported grant, Daniel S. Glaser directly holds 1,380 MetLife common shares. The filing also shows 198 additional shares held indirectly through a Grantor Retained Annuity Trust, reflecting both direct and indirect ownership positions.

Were the new MetLife (MET) shares bought on the market or granted as compensation?

The 273 MetLife shares were granted as compensation, not purchased on the open market. They arise from non-management director retainer fees that are paid partly in common stock under MetLife’s director compensation arrangements.

What does the MetLife (MET) Form 4/A say about deferred compensation for directors?

The filing explains that non-management director retainer fees are partly paid in MetLife common stock. Daniel S. Glaser elected to defer receipt of his 273-share grant under the MetLife Deferred Compensation Plan for Non-Management Directors rather than receiving the shares immediately.

Why are some of Daniel Glaser’s MetLife (MET) shares reported as indirectly owned?

The Form 4/A states that 198 MetLife shares are held in a Grantor Retained Annuity Trust. These were previously reported as directly owned due to administrative error and are now correctly shown as indirectly owned through the trust structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 02:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Daniel S

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NY 10166

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		A(1)		273	A	$75.34	1,380	D
Common Stock								198(2)	I	By GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

2. These shares are held in a Grantor Retained Annuity Trust (GRAT) and were previously reported as directly owned due to administrative error.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.